ATHE (Alterity Therapeutics Limited American Depositary Shares) Stock Analysis - Analyst Ratings

Alterity Therapeutics Limited American Depositary Shares (ATHE) is a publicly traded Healthcare sector company. As of May 19, 2026, ATHE trades at $4.23 with a market cap of $73.05M and a P/E ratio of 0.00. ATHE moved +0.00% today. Year to date, ATHE is +37.18%; over the trailing twelve months it is +5.73%. Its 52-week range spans $1.00 to $7.00. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces ATHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ATHE?

1 analysts cover ATHE: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.00.

ATHE Key Metrics

Key financial metrics for ATHE
MetricValue
Price$4.23
Market Cap$73.05M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$7.00
52-Week Low$1.00
Volume2.00K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

ATHE Analyst Consensus

1 analysts cover ATHE: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Latest ATHE News

Common questions about ATHE

What do analysts rate ATHE?
1 analysts cover ATHE: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.00.
Does Rallies show ATHE price targets?
Yes. Rallies tracks ATHE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ATHE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATHE. It does not provide personalized investment advice.
ATHE

ATHE